TransMedics Group, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | $34.1M | $54.6M | $20.1M |
| FY2020 | $34.7M | $103.9M | $24.6M |
| FY2021 | $35.2M | $67.9M | $25.6M |
| FY2022 | $58.7M | $187.4M | $201.2M |
| FY2023 | — | $137.2M | $394.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | $34.1M | $54.6M | $20.1M |
| FY2020 | $34.7M | $103.9M | $24.6M |
| FY2021 | $35.2M | $67.9M | $25.6M |
| FY2022 | $58.7M | $187.4M | $201.2M |
| FY2023 | — | $137.2M | $394.8M |